Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × avelumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Metastatic Urothelial Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

cabozantinib 1 belinostat 1 atezolizumab 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Etoposide 1 Disulfides 1 Cisplatin 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡